SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-489508"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-489508" > Circulating lipopro...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004049naa a2200433 4500
001oai:DiVA.org:uu-489508
003SwePub
008221201s2022 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:154717409
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4895082 URI
024a https://doi.org/10.1016/j.metabol.2022.1553472 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1547174092 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Larsson, Susanna C.u Karolinska Institutet,Uppsala universitet,Medicinsk epidemiologi,Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.4 aut0 (Swepub:uu)susla720
2451 0a Circulating lipoprotein(a) levels and health outcomes :b Phenome-wide Mendelian randomization and disease-trajectory analyses
264 1b Elsevier,c 2022
338 a print2 rdacarrier
520 a BACKGROUND: Lipoprotein(a) [Lp(a)] is a risk factor for atherosclerotic and valvular diseases, but its possible role in other diseases has not yet been established. We conducted phenome-wide Mendelian randomization and disease-trajectory analyses to assess any associations of circulating Lp(a) levels with a broad range of diseases.METHODS: A weighted polygenic risk score was constructed using independent genetic variants in the LPA gene and with an established effect on Lp(a) levels. The PheWAS analysis included 1081 phenotype outcomes ascertained among 385,917 White participants of the UK Biobank. Novel findings were investigated in MR analysis using data from the FinnGen consortium. Disease-trajectory and comorbidity analyses were further conducted to explore the sequential patterns of multiple morbidities related to high circulating Lp(a) levels.RESULTS: PheWAS revealed statistically significant associations of higher circulating Lp(a) levels with increased risk of a large number of circulatory system diseases (including various cardiac diseases, peripheral vascular disease, hypertension, and valvular and cerebrovascular diseases) as well as some endocrine/metabolic diseases (including hyperlipidemia, hypercholesterolemia, disorders of lipoid metabolism, and type 2 diabetes), genitourinary system diseases (renal failure), and hematologic diseases (including different types of anemia). Two-sample MR analysis supported the association between Lp(a) and risk of anemia, showed a suggestive association with type 2 diabetes, but found no association with renal failure. Disease-trajectory and comorbidity analyses identified 3 major sequential patterns of multiple morbidities, mainly in the cardiovascular, metabolic, and mental disorders, related to high circulating Lp(a) levels.CONCLUSIONS: Genetically predicted higher circulating Lp(a) levels were associated with increased risk of many circulatory system diseases and anemia. Additionally, this study identified three major sequential patterns of multiple morbidities related to high Lp(a).
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
653 a Anemia
653 a Lipoprotein(a)
653 a Mendelian randomization
653 a PheWAS
653 a Type 2 diabetes
700a Wang, Lijuan4 aut
700a Li, Xue4 aut
700a Jiang, Fangyuan4 aut
700a Chen, Xiangjun4 aut
700a Mantzoros, Christos S4 aut
710a Uppsala universitetb Medicinsk epidemiologi4 org
773t Metabolismd : Elsevierg 137q 137x 0026-0495x 1532-8600
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-489508
8564 8u https://doi.org/10.1016/j.metabol.2022.155347
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:154717409

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy